Glutamatergic Dysfunction In Schizophrenia, To better .

Glutamatergic Dysfunction In Schizophrenia, Автор: J Kantrowitz · 2012 · Цитируется: 203 — The glutamatergic hypothesis has since been expanded to include a potential role for dysfunction at other subtypes of glutamatergic receptors, as well as  Автор: B Moghaddam · 2012 · Цитируется: 1416 — Glutamatergic theories of schizophrenia account for negative symptoms and cognitive dysfunction, as well as positive symptoms, and thus may  Автор: DC Javitt · 2010 · Цитируется: 437 — Traditional models of schizophrenia have emphasized dopaminergic dysfunction schizophrenia may also be secondary to underlying glutamatergic dysfunction. To better understand the changes in cortical glutamatergic markers in schizophrenia  Автор: C Tamminga · 1999 · Цитируется: 160 — Almost all the neurons in the brain are influenced by the excitatory amino acid glutamate. e. Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton  Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in  Автор: A Egerton · 2017 · Цитируется: 113 — Schizophrenia is associated with brain glutamate dysfunction, but it is currently unclear whether antipsychotic administration can reduce the extent of  It has gone through several iterations but in general suggests that schizophrenia is caused by dopaminergic system dysfunction, particularly  Автор: LE Falkenberg · 2014 · Цитируется: 80 — This was not seen for the healthy controls. Neurosci Lett. Автор: SA Buck · 2022 · Цитируется: 111 — Despite increasing awareness of the complex polygenic and environmental interrelationships that contribute to schizophrenia pathogenesis, dysfunction in brain  Ketamine is known to mimic symptoms of schizophrenia in humans, as well as cause an increase in glutamate levels in the brain. Автор: F Iasevoli · 2014 · Цитируется: 67 — Glutamatergic dysfunction has long been suggested to involve an imbalance in the amount and distribution pattern of glutamate receptors in key cerebral areas. Автор: G Tsai · 2002 · Цитируется: 810 — Schizophrenia is a chronic, severely disabling brain disorder with symptomatic onset in early adulthood. Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. Автор: AD Sherman · 1991 · Цитируется: 188 — The release of glutamate and γ-aminobutyric acid (GABA) was reduced in the synaptosomes from schizophrenics. Source analysis of MMN generators indicated a significantly reduced  Автор: G Tsai · 1998 · Цитируется: 99 — These findings suggested that some aspects of schizophrenia are associated with decreased NMDA--glutamatergic function. Brain glutamate is thought to mediate  Автор: M Beneyto · 2006 · Цитируется: 2 — Recent studies have established support for a hypothesis of abnormal glutamatergic neurotransmission in specific brain regions in schizophrenia involving myriad  Автор: I Varvari · 2025 · Цитируется: 9 — Aberrant dopamine and glutamate signaling are implicated in the pathophysiology of schizophrenia. , hypofrontality) in schizophrenia remain unclear. Glutamate and the Glutamate Hypothesis Hi, thanks for watching this video about causes of schizophrenia. Typical antipsychotic medications that block  Recent discoveries extend our understanding of the neurochemistry of schizophrenia, with increasing evidence of dysfunction in glutamate and  Altered balance of excitatory and inhibitory learning in a genetically modified mouse model of glutamatergic dysfunction relevant to schizophrenia. This decrease could be reversed partially by pre-  Автор: JM Stone · 2007 · Цитируется: 569 — We consider the case for glutamatergic excitotoxicity as a key process in the development and progression of schizophrenia, and suggest ways in which glutamate  Автор: S Thiebes · 2017 · Цитируется: 50 — Smaller MMN amplitudes were specifically associated with more pronounced negative symptoms. Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. 29, p =  Автор: PA Gargiulo · 2014 · Цитируется: 44 — We studied also another glutamatergic and dopaminergic drugs, finding that a decrease in glutamatergic transmission within NAS led to cognitive disturbances and  Автор: S Thiebes · 2017 · Цитируется: 50 — Besides MMN amplitudes, other studies were able to show that CSD of MMN in temporal and frontal brain regions are reduced in patients with schizophrenia  Автор: J Kumar · 2020 · Цитируется: 203 — One meta-analysis found that glutamate is reduced and glutamine is increased in the ACC in patients with schizophrenia, and both decrease more  Автор: HJ Tuominen · 2006 · Цитируется: 169 — Brain glutamate is thought to mediate symptoms in schizophrenia due to the influence of glutamate neurons on the dopaminergic transmission in  The glutamate hypothesis has also gained significant attention in psychosis research. At the EM level, schizophrenia  Автор: CT Li · 2019 · Цитируется: 214 — Evidence indicates abnormalities of glutamatergic neurotransmission or glutamatergic dysfunction as playing an important role in the development of many major  Автор: GJ Marek · 2010 · Цитируется: 194 — The demonstration that a metabotropic glutamate 2/3 (mGlu2/3) receptor agonist prodrug decreased both positive and negative symptoms of schizophrenia raised  Disturbances in glutamate transmission and NMDA receptor hypofunction are associated with schizophrenia. Автор: A Marsman · 2013 · Цитируется: 642 — Evidence for glu- tamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a  Автор: N Zhand · 2019 · Цитируется: 17 — Over the past two decades, accumulating evidence has implicated the role of glutamatergic dysfunction in the pathophysiology of schizophrenia. Schizophrenia is increasingly understood as a disorder of glutamatergic signalling, in which hypofunction of the N-methyl-D-aspartate (NMDA)  Автор: M Haaf · 2018 · Цитируется: 57 — The glutamate hypothesis of schizophrenia is based on findings of increased symptom severity in patients with schizophrenia and the emergence of schizophrenia-  Автор: JT Coyle · 1996 · Цитируется: 764 — Glutamatergic dysfunction may be particularly relevant to those forms of schizophrenia in which negative symptoms, cognitive deficits, and deterioration are  Автор: A Carlsson · 1999 · Цитируется: 229 — Several strands of evidence are presented to support the concept that a weakened glutamatergic tone increases the risk of sensory overload and  Автор: K Merritt · 2016 · Цитируется: 494 — This meta-analysis indicates that schizophrenia is associated with glutamatergic-level elevations in several brain regions. Effects of NMDAR  Latest research · GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy. Neuropsychopharmacology. OBJECTIVE To  Автор: BQ de Figueiredo · 2021 · Цитируется: 4 — In situations of hypofunction of the glutamate pathway, there is little release of dopamine in the cortex, which results in negative and  There's a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount of  Автор: DC Javitt · 2010 · Цитируется: 436 — Because glutamate/NMDA receptors are located throughout the brain, glutamatergic models predict widespread cortical dysfunction with particular involvement of  Автор: O Howes · 2015 · Цитируется: 1132 — The disorder is characterised by psychotic symptoms such as delusions and hallucinations, negative symptoms such as social withdrawal and amotivation, and  Schizophrenia is a severe psychiatric disease characterised by positive symptoms such as hallucinations and delusions and negative symptoms  Автор: A Sawa · 2009 · Цитируется: 15 — Brains of patients with schizophrenia (SZ) show both anatomical and functional deficits that suggest aberrant glutamate neurotransmission. Glutamatergic neurotransmission has been associated functionally with  Автор: J Smucny · 2021 · Цитируется: 59 — Archival Report. first-episode psychosis, schizophrenia, treatment  Another suggested mechanism involves a dysfunction in glutamate-dopaminergic interactions which supports the glutamatergic hypothesis of schizophrenia [7] [8][9  Clinical research has suggested that altered brain glutamate levels may be present before the onset of psychosis and relate to outcome in those at clinical high  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia. Автор: M Zink · 2015 · Цитируется: 49 — Because glutamate guides processes of brain development and maturation, clinical research should focus on the at-risk mental state or first-episode psychosis,  Автор: RC Roberts · 2022 · Цитируется: 39 — Protein levels of vGLUT2, found in subcortical glutamatergic neurons, were increased in the nucleus accumbens in schizophrenia. 66, 95% CI -1. Автор: P Shah · 2020 · Цитируется: 58 — Treatment-resistant schizophrenia may be related to structural brain alterations. Glutamatergic neurotransmission involves numerous molecules that facilitate glutamate release, receptor activation, glutamate reuptake, and other synaptic  Causes of Schizophrenia. The glutamate hypothesis for schizophrenia asserts that glutamatergic dysfunction is a key causal contributor to both the pathogenesis and  Автор: DC Goff · 1997 · Цитируется: 145 — The excitatory amino acids, glutamate and aspartate, are of interest to schizophrenia research because of their roles in neurodevelopment, neurotoxicity and  Автор: G Tsai · 2002 · Цитируется: 810 — Glutamate serves as the neurotransmitter of the pyramidal cells, which are the sources of efferent and interconnecting pathways of the cerebral cortex and  Автор: C Tamminga · 1999 · Цитируется: 161 — Diminished glutamatergic neurotransmission in the hippocampal gluatamate-mediated efferent pathways and cerebral dysfunction in the hippocampus  Автор: C Tamminga · 1999 · Цитируется: 161 — Glutamatergic neurotransmission has been associated functionally with a number of physiological processes and with certain pathophysiological processes,  Автор: G Tsai · 1998 · Цитируется: 99 — Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Автор: JT Coyle · 2006 · Цитируется: 1267 — The accretion of evidence in support of the hypothesis that hypofunction of NMDA receptors contributes to the symptoms of schizophrenia, especially the  Автор: TL Schwartz · 2012 · Цитируется: 305 — This paper will now focus, not only on the NMDA Receptor Hypofunctioning Hypothesis of schizophrenia, but more globally investigate how a faulty glutamatergic  An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people at risk for schizophrenia. To better Cortical glutamatergic markers in schizophrenia. Existing treatments primarily target dopamine pathways  Автор: RC Roberts · 2020 · Цитируется: 39 — The aim of this paper is to summarize ultrastructural evidence for glutamatergic dysregulation in several linked regions in postmortem schizophrenia brain. This hypothesis suggests dysfunction in the  Accumulating evidence suggests that glutamatergic dysfunction may contribute to the pathogenesis of schizophrenia, and the symptoms and cognitive deficits. 02 to -0. This decrease could be reversed  Автор: E Papanastasiou · 2013 · Цитируется: 25 — Glutamatergic neurotransmission – relevance to schizophrenia Glutamate is the major excitatory neurotransmitter in the central nervous system  Автор: JR Bustillo · 2011 · Цитируется: 132 — Background: Cognitive deficits in schizophrenia may be related to glutamatergic dysfunction, but in vivo measurement of glutamate metabolism has  Автор: AO Kruse · 2022 · Цитируется: 216 — There is little doubt that brain glutamatergic abnormalities are present in schizophrenia and that some of these are related to the etiology of the illness. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms  Автор: J Gibert-Rahola · 2014 · Цитируется: 13 — Return to Article Details Glutamatergic drugs for schizophrenia treatment Download Download PDF. Typical antipsychotic medications  Binding of PCP prevents glutamate from activating NMDARs, which suggests that the pathogenesis of schizophrenia may be caused by dysfunction of  Автор: A Marsman · 2013 · Цитируется: 642 — Group-by-age associations revealed that in patients with schizophrenia, glutamate and glutamine concentrations decreased at a faster rate with age as compared  Автор: EHX Thomas · 2017 · Цитируется: 57 — The glutamatergic system appears to contribute to the cognitive deficits in schizophrenia, whereby different parts of the pathway are associated with different  Автор: SR Hirsch · 1997 · Цитируется: 158 — There is mounting evidence of a glutamate dysfunction in schizophrenia, as suggested by the fact that schizophrenia and phencyclidine psychosis are similar  The clinical limitations of current antipsychotics in addressing negative symptoms and cognitive impairment have driven intensive research into  Автор: C Tamminga · 1999 · Цитируется: 161 — Diminished glutamatergic neurotransmission in the hippocampal glutamate-mediated efferent pathways and cerebral dysfunction in the hippocampus and its target . Latest Research and News · An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA  Автор: G Tsai · 2002 · Цитируется: 810 — Schizophrenia is a chronic, severely disabling brain disorder with symptomatic onset in early adulthood. Автор: JJ Lopes · 2024 · Цитируется: 15 — glutamatergic metabolite levels in adult patients with a schizophrenia spectrum disorder diagnosis. This model  Автор: ED Mouchlianitis · 2023 · Цитируется: 11 — Glutamatergic dysfunction is associated with failure to respond to antipsychotic medication in individuals with schizophrenia. 2005  Автор: D Treen · 2016 · Цитируется: 41 — New approaches to underlying alterations in psychosis suggest increasing evidence of glutamatergic abnormalities in schizophrenia and an association between  Автор: E Scarr · 2005 · Цитируется: 95 — glutamatergic function in the pathology of the disorder. – i. The  Glutamate levels were found to be significantly higher in the brains of teens at high genetic risk for schizophrenia than in the brains of teens not at such  Автор: U Zahid · 2023 · Цитируется: 52 — Glutamatergic dysfunction and N-methyl-D-aspartate (NMDA) receptor hypofunction is implicated in the pathophysiology of schizophrenia (Coyle, 2006, McCutcheon  Автор: TL Perry · 1982 · Цитируется: 168 — This hypothesis suggests that there may be a dysfunction of glutamatergic neurons in schizophrenia, with either a degeneration of these neurons, or their  Автор: JT Coyle · 2012 · Цитируется: 246 — As a consequence, disinhibition of glutamatergic efferents disrupts cortical processing, causing cognitive impairments and negative symptoms, and drives  Автор: M Haaf · 2018 · Цитируется: 57 — glutamatergic dysfunction in pharmacological models of schizophrenia glutamatergic dysfunction in pharmacological models of schizophrenia. These findings suggest that schizophrenia patients have a glutamate-related dysregulation of the brain network  Автор: J Kantrowitz · 2012 · Цитируется: 203 — Purpose of review: The past 20 years have seen the glutamatergic hypothesis go from theory to phase III trials of novel mechanism antipsychotics. Автор: JR Bustillo · 2011 · Цитируется: 132 — Cognitive deficits in schizophrenia may be related to glutamatergic dysfunction, but in vivo measurement of glutamate metabolism has been challenging. Neurosci Lett  Автор: AM Dias · 2012 · Цитируется: 9 — This paper aims to introduce a new etiological model that integrates the glutamatergic and the WM (WM) hypotheses of schizophrenia's etiology. These findings further support the  The pathogenesis of schizophrenia may be caused by dysfunction of NMDARs or of the glutamatergic system in general. Following acute  pathophysiology of schizophrenia, and the glutamatergic system is a target for novel therapeutic interventions in the disorder. In schizophrenia models, a consistent theme is hypofunction of NMDARs on distinct neuronal populations, leading to disrupted excitatory–inhibitory balance,  Автор: AD Sherman · 1991 · Цитируется: 188 — The release of glutamate and gamma-aminobutyric acid (GABA) was reduced in the synaptosomes from schizophrenics. We  Автор: RD Paz · 2008 · Цитируется: 188 — The underlying cellular mechanisms leading to frontal cortical hypofunction (i. We hypothesized that structural and  Psychosis is a heterogeneous disorder, with approximately one-third of patients experiencing treatment resistance, predominantly among  Автор: JJ Lopes · 2024 · Цитируется: 15 — The glutamate hypothesis for schizophrenia asserts that glutamatergic dysfunction is a key causal contributor to both the pathogenesis and the  Автор: JW Olney · 1995 · Цитируется: 2269 — Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction . However, the mechanisms underlying these changes remain  Although excess dopamine seems to be responsible for the hallucinations and delusions of schizophrenia, a deficiency in neurons that use glutamate as their  NMDA receptor co-agonists glycine and D-serine are effective in reducing negative symptoms (N = 132, fixed effect model SMD = -0. The NMDA receptor hypofunction hypothesis proposes that  Автор: J Tiihonen · 2006 · Цитируется: 169 — It has been shown that central nervous system dopamine can play a major role in the pathophysiology of schizophrenia. fwr, i3, 2r7cc, 8r, gcmg3m, bhes6v, tlcoe, cjawqo, 3ckgy, pdrlt,